A detailed history of Securian Asset Management, Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Securian Asset Management, Inc holds 1,977 shares of MEDP stock, worth $614,115. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,977
Previous 1,867 5.89%
Holding current value
$614,115
Previous $768,000 14.19%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$320.58 - $457.29 $35,263 - $50,301
110 Added 5.89%
1,977 $659,000
Q2 2024

Jul 15, 2024

SELL
$372.0 - $424.34 $37,200 - $42,434
-100 Reduced 5.08%
1,867 $768,000
Q3 2023

Oct 30, 2023

SELL
$233.98 - $281.67 $52,879 - $63,657
-226 Reduced 10.31%
1,967 $476,000
Q2 2023

Aug 07, 2023

SELL
$187.26 - $240.17 $18,726 - $24,017
-100 Reduced 4.36%
2,193 $526,000
Q3 2022

Oct 28, 2022

SELL
$145.13 - $182.49 $22,204 - $27,920
-153 Reduced 6.26%
2,293 $360,000
Q2 2022

Aug 04, 2022

SELL
$130.2 - $168.03 $13,019 - $16,803
-100 Reduced 3.93%
2,446 $366,000
Q1 2022

May 03, 2022

SELL
$138.87 - $214.31 $13,887 - $21,431
-100 Reduced 3.78%
2,546 $417,000
Q4 2021

Feb 10, 2022

BUY
$182.74 - $227.9 $18,274 - $22,790
100 Added 3.93%
2,646 $576,000
Q2 2021

Aug 10, 2021

SELL
$158.62 - $194.3 $16,020 - $19,624
-101 Reduced 3.82%
2,546 $450,000
Q1 2021

May 10, 2021

BUY
$132.02 - $168.26 $13,202 - $16,826
100 Added 3.93%
2,647 $434,000
Q4 2020

Feb 08, 2021

SELL
$109.38 - $149.19 $10,938 - $14,919
-100 Reduced 3.78%
2,547 $355,000
Q3 2020

Nov 04, 2020

BUY
$92.95 - $130.61 $246,038 - $345,724
2,647 New
2,647 $296,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Securian Asset Management, Inc Portfolio

Follow Securian Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.